Use of anthrax vaccine in the United States
- PMID: 11145529
Use of anthrax vaccine in the United States
Abstract
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical